QSS
CBAY

Quantitative Systematic Strategies’s Cymabay Therapeutics CBAY Stock Holding History

Quantitative Systematic Strategies’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-35,430
Closed -$181K – 673
2019
Q3 		$181K Buy
35,430
+253
+0.7% +$1.53K 0.04% 417
2019
Q2 		$252K Buy
+35,177
New +$398K 0.05% 372
2019
Q1 		– Sell
-18,336
Closed -$144K – 690
2018
Q4 		$144K Sell
18,336
-5,014
-21% -$47.7K 0.03% 572
2018
Q3 		$259K Buy
+23,350
New +$290K 0.05% 455

Other funds holding CBAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Quantitative Systematic Strategies's CBAY Position: Q4 2019 in Review

Quantitative Systematic Strategies sold out of Cymabay Therapeutics (CBAY) in Q4 2019, closing a stake of 35,430 shares — an estimated $181K sold.

Quantitative Systematic Strategies first reported a position in CBAY in Q3 2018 and held it in 4 quarters. The position peaked at $259K in Q3 2018. 113 funds tracked by Wall St. Rank hold CBAY as of Q4 2019.

  • Quantitative Systematic Strategies reported no remaining Cymabay Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 35,430 Cymabay Therapeutics shares in Q4 2019, an estimated $181K.
  • Quantitative Systematic Strategies first reported a position in Cymabay Therapeutics in Q3 2018 and held it in 4 quarters.
  • Quantitative Systematic Strategies's Cymabay Therapeutics position peaked at $259K in Q3 2018.
  • 113 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2019, filed 11 Feb 2020.